Antioxidants and Redox Signaling 2015-08-01

Sulfite Oxidase Catalyzes Single-Electron Transfer at Molybdenum Domain to Reduce Nitrite to Nitric Oxide.

Jun Wang, Sabina Krizowski, Katrin Fischer-Schrader, Dimitri Niks, Jesús Tejero, Courtney Sparacino-Watkins, Ling Wang, Venkata Ragireddy, Sheila Frizzell, Eric E Kelley, Yingze Zhang, Partha Basu, Russ Hille, Guenter Schwarz, Mark T Gladwin

Index: Antioxid. Redox Signal. 23 , 283-94, (2015)

Full Text: HTML

Abstract

Recent studies suggest that the molybdenum enzymes xanthine oxidase, aldehyde oxidase, and mARC exhibit nitrite reductase activity at low oxygen pressures. However, inhibition studies of xanthine oxidase in humans have failed to block nitrite-dependent changes in blood flow, leading to continued exploration for other candidate nitrite reductases. Another physiologically important molybdenum enzyme—sulfite oxidase (SO)—has not been extensively studied.Using gas-phase nitric oxide (NO) detection and physiological concentrations of nitrite, SO functions as nitrite reductase in the presence of a one-electron donor, exhibiting redox coupling of substrate oxidation and nitrite reduction to form NO. With sulfite, the physiological substrate, SO only facilitates one turnover of nitrite reduction. Studies with recombinant heme and molybdenum domains of SO indicate that nitrite reduction occurs at the molybdenum center via coupled oxidation of Mo(IV) to Mo(V). Reaction rates of nitrite to NO decreased in the presence of a functional heme domain, mediated by steric and redox effects of this domain. Using knockdown of all molybdopterin enzymes and SO in fibroblasts isolated from patients with genetic deficiencies of molybdenum cofactor and SO, respectively, SO was found to significantly contribute to hypoxic nitrite signaling as demonstrated by activation of the canonical NO-sGC-cGMP pathway.Nitrite binds to and is reduced at the molybdenum site of mammalian SO, which may be allosterically regulated by heme and molybdenum domain interactions, and contributes to the mammalian nitrate-nitrite-NO signaling pathway in human fibroblasts.SO is a putative mammalian nitrite reductase, catalyzing nitrite reduction at the Mo(IV) center.


Related Compounds

Related Articles:

H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway.

2015-03-30

[Oncotarget 6(9) , 6877-86, (2015)]

Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.

2015-04-01

[Am. J. Physiol. Cell Physiol. 308(7) , C557-69, (2015)]

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.

2015-12-01

[Clin. Exp. Immunol. 182 , 289-301, (2015)]

Down regulation of NO signaling in Trypanosoma cruzi upon parasite-extracellular matrix interaction: changes in protein modification by nitrosylation and nitration.

2015-04-01

[PLoS Negl. Trop. Dis. 9 , e0003683, (2015)]

Immunomodulatory effects of Lippia sidoides extract: induction of IL-10 through cAMP and p38 MAPK-dependent mechanisms.

2015-03-01

[J. Med. Food 18(3) , 370-7, (2015)]

More Articles...